Vir Biotechnology, Inc. (VIR) Operating margin 2017–2025
Vir Biotechnology, Inc. (VIR) operating margin by fiscal year — reported operating income divided by reported revenue.
-699.2%FY2025 · since FY2017: -3009.5% → -699.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -699.2% | +92.1 pp |
| FY2024 | -791.3% | +2.8 pp |
| FY2023 | -794.0% | -845.6 pp |
| FY2022 | 51.6% | +13.1 pp |
| FY2021 | 38.4% | +427.3 pp |
| FY2020 | -388.9% | +1810.8 pp |
| FY2019 | -2199.7% | -1087.1 pp |
| FY2018 | -1112.6% | +1896.9 pp |
| FY2017 | -3009.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice